Article Details

Hansa Biopharma announces $70 million finance transaction with NovaQuest

Retrieved on: 2022-07-25 10:23:50

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma announces $70 million finance transaction with NovaQuest. View article details on hiswai:

Excerpt

Hansa Biopharma AB, (Hansa), an enzyme technology for rare immunological conditions, secures $70 million in non-dilutive financing.

Article found on: www.businessleader.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up